Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer
Phase 1/2 Completed
264 enrolled 41 charts
A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers.
Phase 1/2 Completed
30 enrolled 17 charts
Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients
Phase 1/2 Completed
45 enrolled
MYCA
Phase 1/2 Completed
87 enrolled
Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma
Phase 1/2 Completed
28 enrolled 10 charts
Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer
Phase 1/2 Completed
53 enrolled 22 charts
Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer
Phase 1/2 Completed
2 enrolled 1 chart
Trientine
Phase 1/2 Completed
18 enrolled 16 charts
Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer
Phase 1/2 Completed
39 enrolled 4 charts
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Phase 1/2 Completed
24 enrolled 14 charts
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer
Phase 1/2 Completed
30 enrolled 13 charts
RVDD
Phase 1/2 Completed
74 enrolled 6 charts
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer
Phase 1/2 Completed
45 enrolled 8 charts
PITCH
Phase 1/2 Completed
21 enrolled
Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)
Phase 1/2 Completed
58 enrolled 11 charts
Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)
Phase 1/2 Completed
138 enrolled
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
Phase 1/2 Completed
107 enrolled
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
Phase 1/2 Completed
63 enrolled